ACHC · XBRL financial data

Acadia Healthcare Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (ACHC's year ends in late December)

In millions of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Revenue from contracts with customers	731	750	743*	768	796	816	774*	771	869	852	821*	829
General and administrative	—	—	year only	—	—	—	year only	—	—	—	year only	—
Income tax expense (benefit)	23	(72)	20*	20	26	27	4*	4	12	2	8*	7
Net income (loss)	72	(218)	58	76	78	68	33	8	30	36	(1,178)	4
Earnings per share, basic USD per share	0.79	(2.39)	—	0.84	0.86	0.74	—	0.09	0.33	0.40	—	0.05
Earnings per share, diluted USD per share	0.79	(2.39)	—	0.83	0.85	0.74	—	0.09	0.33	0.40	—	0.05
Weighted average shares, basic millions of shares	91	91	91*	91	92	92	92*	92	90	90	90*	91
Weighted average shares, diluted millions of shares	92	91	90*	92	92	92	92*	92	90	91	90*	91

Fiscal quarters (ACHC's year ends in late December)

In millions of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Cash and cash equivalents	112	100	100	77	77	82	76	91	131	119	133	158
Accounts receivable	346	363	361	386	389	384	365	397	409	431	441	472
Inventory	5	5	5	6	6	6	6	6	6	6	6	6
Total current assets	579	703	596	611	645	652	577	639	692	748	814	837
Property and equipment, net	2,074	2,146	2,267	2,376	2,498	2,680	2,853	2,956	3,064	3,092	3,111	3,107
Right-of-use asset	128	122	118	121	123	123	118	121	113	114	134	132
Goodwill	2,223	2,226	2,226	2,261	2,261	2,265	2,265	2,276	2,276	2,286	1,296	1,301
Total assets	5,150	5,346	5,359	5,517	5,678	5,870	5,957	6,148	6,308	6,413	5,527	5,546
Accounts payable	149	150	156	156	160	201	233	204	220	180	150	142
Current portion of long-term debt	24	27	29	61	67	72	77	16	20	24	28	33
Total current liabilities	432	865	886	482	547	610	578	473	524	518	525	489
Long-term debt	1,372	1,350	1,343	1,794	1,775	1,805	1,880	2,184	2,247	2,285	2,472	2,494
Lease liability, non-current	111	105	101	103	105	105	102	101	95	95	122	121
Total liabilities	2,139	2,536	2,471	2,542	2,613	2,724	2,766	2,974	3,085	3,123	3,387	3,378
Retained earnings (accumulated deficit)	292	74	132	208	287	355	387	348	375	412	(766)	(762)
Total stockholders' equity	2,921	2,713	2,782	2,866	2,953	3,032	3,074	3,042	3,078	3,120	1,949	1,958
Total liabilities and equity	5,150	5,346	5,359	5,517	5,678	5,870	5,957	6,148	6,308	6,413	5,527	5,546
Common shares outstanding (cover page) millions of shares	92	92	92	93	93	93	93	92	92	92	92	91

Fiscal quarters (ACHC's year ends in late December)

In millions of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Net income (loss)	72	(218)	58	76	78	68	33	8	30	36	(1,178)	4
Stock-based compensation	7	8	9*	9	9	9	10*	9	11	6	6*	8
Net cash from operating activities	164*	138*	116*	(321)	171*	163*	117*	11	134*	73*	(86)*	62
Purchases of property and equipment	91*	128*	139*	142	154*	190*	203*	175	168*	136*	93*	77
Net cash from investing activities	(91)*	(129)*	(110)*	(185)	(155)*	(193)*	(203)*	(183)	(151)*	(130)*	(92)*	(60)
Share repurchases	—	—	—	—	—	—	—	47	3*	0*	0*	—
Proceeds from long-term debt	—	—	—	350	0*	0*	0*	1,200	0*	0*	0*	—
Net cash from financing activities	(25)*	(21)*	(6)*	483	(16)*	35*	81*	187	57*	44*	193*	24
Net change in cash	48*	(13)*	0*	(23)	(0)*	5*	(6)*	15	40*	(13)*	15*	25

SIC 8093 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8093 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Acadia Healthcare Company	163	895	98*	93.0M	Q3 FY26 10-QSep 30, 2026
Progyny	153	351	50*	76.7M	Q2 FY26 10-QJun 30, 2026
Concentra Group Holdings Parent	158	606	135*	127.5M	Q2 FY26 10-QJun 30, 2026
Sotera Health	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
agilon health	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.